Skip to content

Drug-stimulated biomarker turnover

How does repeated exposure accelerate biomarker removal? Explore fixed regimens and bounded dose-amplitude optimization in normalized benchmark units. No clinical dose, patient prediction, global optimum, or paper-figure agreement is claimed.

Exploration notes · What are you exploring?

Notes stay on this browser.

MODEL IN MOTION 18 sec

How does a biomarker respond after the exposure pulse?

Run settings

Run location

Explore this model

Choose a scenario, adjust inputs, and run the simulation.

Lower exposure

How does repeated exposure accelerate biomarker removal?

0–42 day

Scenario details

Lower exposure

How does repeated exposure accelerate biomarker removal?

Readouts

Biomarker · dimensionless
Explore fixed regimens and bounded dose-amplitude optimization in normalized benchmark units. No clinical dose, patient prediction, global optimum, or paper-figure agreement is claimed.
Drug exposure · dimensionless
Explore fixed regimens and bounded dose-amplitude optimization in normalized benchmark units. No clinical dose, patient prediction, global optimum, or paper-figure agreement is claimed.
Drug concentration · dimensionless
Explore fixed regimens and bounded dose-amplitude optimization in normalized benchmark units. No clinical dose, patient prediction, global optimum, or paper-figure agreement is claimed.

Study purpose

  • How does repeated exposure accelerate biomarker removal?

Assumptions

  • Regimens and dose optimization use normalized benchmark units. Optimization does not establish a global optimum.

Inputs changed since the displayed result. Run to update the comparison.

Loading starting example…

Edit inputs

Turnover / binding

Drug elimination rate

1/day

Suggested: 0.245–0.735. You can explore beyond this range.

0.49 → —
Benchmark scaling

Maximum removal stimulation

—

Suggested: 4.4–13.2. You can explore beyond this range.

8.8 → —

Half-maximal effect concentration

—

Suggested: 0.405–1.22. You can explore beyond this range.

0.81 → —
Simulation time
day
day
42 → 168

Time between reported samples.

day
0.1 → 1

2 changes · Variation 1

Continue in the background and keep the result.

Optimize dose amplitudes

Administration times and model parameters stay fixed. Adjust starting amplitudes within the declared bounds, then compare the optimized response with the target.

Fixed-time benchmark amplitude optimization; not a clinical regimen or a paper-optimum reproduction.

Sign in to preview and run dose optimization.

Biology

How does repeated exposure accelerate biomarker removal?

How does repeated exposure accelerate biomarker removal?

Model details

6 parameters · 2 states · 2 equations · 3 derived outputs

Classification & API access
Therapeutic
generic biomarker-removal stimulus
Modality
Other biologic or therapeutic modality
Target
generic biomarker turnover pathway
Disease / scope
Mechanism-agnostic biomarker turnover research
ParameterDefaultUnitDescription
Half-maximal effect concentrationEC500.81—Half-maximal effect concentration
Maximum effectEmax8.8—Maximum removal stimulation
Apparent distribution volumeV3—Benchmark volume ratio
Elimination rate constantkel0.491/dayDrug elimination rate
Biomarker production ratekin0.921/dayBiomarker production rate
Turnover loss ratekout0.021/dayBaseline biomarker removal rate

Related models

Drug injury and delayed tumor lossBispecific exposure and ternary binding

Feedback: helpdesk@unibiointelligence.com.

Ubi Biologics